You must score at least 70% in this module to pass. Ensure you have read ‘Cancer-associated thrombosis’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
0 of 15 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 15 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
The All Party Parliamentary Thrombosis Group (APPTG) 2016 reviewed the state of cancer-associated thrombosis in the UK. Which of the following is a correct statement made by APPTG?CorrectIncorrect
The Virchow’s triad has formed the basis of our understanding of the pathogenesis of venous thromboembolism for some time. Virchow’s triad model proposed that factors that increase the risk of thrombosis may be broadly divided into three cancer-associated thrombosis categories. Which statement shows the three categories included in Virchow’s triad?CorrectIncorrect
Risk factors for the development of cancer-associated thrombosis can be both general and specific to patients with cancer. Which statement is correct for common risk factors specific to patients with cancer?CorrectIncorrect
In a meta-analysis, which cancer has the highest risk of cancer-associated thrombosis?CorrectIncorrect
Cancer-associated thrombosis is an important cause of morbidity and mortality in patients with cancer. Which statement is correct?CorrectIncorrect
Based on current guidelines, which statement is correct?CorrectIncorrect
Treatment of cancer-associated thrombosis (lower extremity venous thrombosis/pulmonary embolism) is with anticoagulant therapies. Which anticoagulants are licensed for the treatment of cancer-associated thrombosis in the first six months?CorrectIncorrect
National and international organisation have based their recommendations on the initial treatment of cancer-associated thrombosis (lower extremity venous thrombosis/pulmonary embolism) to use:CorrectIncorrect
Regarding the risk of bleeding, which statement is correct?CorrectIncorrect
Which one of the following statements regarding use of anticoagulation beyond six months in cancer-associated thrombosis is correct?CorrectIncorrect
Which of the following is correct in relation to venous thromboembolism (VTE) extension/recurrence while on anticoagulation?CorrectIncorrect
Which one of the following is correct in terms of the prevention of venous thromboembolism in patients with myeloma?CorrectIncorrect
Which one of the following is correct in terms of the prevention of venous thromboembolism in ambulatory chemotherapy patients?CorrectIncorrect
Which of the following is correct in terms of the prevention of venous thromboembolism in ambulatory patients who have surgery for cancer?CorrectIncorrect
Which one of the following is correct in terms of the cancer-associated thrombosis patient’s journey?CorrectIncorrect